Transition From Temporary to Durable Circulatory Support Systems.


Journal

Journal of the American College of Cardiology
ISSN: 1558-3597
Titre abrégé: J Am Coll Cardiol
Pays: United States
ID NLM: 8301365

Informations de publication

Date de publication:
22 12 2020
Historique:
received: 30 09 2020
accepted: 13 10 2020
entrez: 18 12 2020
pubmed: 19 12 2020
medline: 12 3 2021
Statut: ppublish

Résumé

The decision to implant durable mechanical circulatory systems (MCSs) in patients on extracorporeal life support (ECLS) is challenging due to expected poor outcomes in these patients. The aim of this study was to identify outcome predictors that may facilitate future patient selection and decision making. The Durable MCS after ECLS registry is a multicenter retrospective study that gathered data on consecutive patients who underwent MCS implantation after ECLS between January 2010 and August 2018 in 11 high-volume European centers. Several perioperative parameters were collected. The primary endpoint was survival at 1 year after durable MCS implantation. A total of 531 durable MCSs after ECLS were implanted during this period. The average patient age was 53 ± 12 years old. ECLS cannulation was peripheral in 87% of patients and 33% of the patients had history of cardiopulmonary resuscitation before ECLS implantation. The 30-day, 1-year, and 3-year actuarial survival rates were 77%, 53%, and 43%, respectively. The following predictors for 1-year outcome have been observed: age, female sex, lactate value, Model of End-Stage Liver Disease XI score, history of atrial fibrillation, redo surgery, and body mass index >30 kg/m The outcome in patients receiving durable MCS after ECLS remains limited, yet preoperative factors may allow differentiating futile patients from those with significant survival benefit.

Sections du résumé

BACKGROUND
The decision to implant durable mechanical circulatory systems (MCSs) in patients on extracorporeal life support (ECLS) is challenging due to expected poor outcomes in these patients.
OBJECTIVES
The aim of this study was to identify outcome predictors that may facilitate future patient selection and decision making.
METHODS
The Durable MCS after ECLS registry is a multicenter retrospective study that gathered data on consecutive patients who underwent MCS implantation after ECLS between January 2010 and August 2018 in 11 high-volume European centers. Several perioperative parameters were collected. The primary endpoint was survival at 1 year after durable MCS implantation.
RESULTS
A total of 531 durable MCSs after ECLS were implanted during this period. The average patient age was 53 ± 12 years old. ECLS cannulation was peripheral in 87% of patients and 33% of the patients had history of cardiopulmonary resuscitation before ECLS implantation. The 30-day, 1-year, and 3-year actuarial survival rates were 77%, 53%, and 43%, respectively. The following predictors for 1-year outcome have been observed: age, female sex, lactate value, Model of End-Stage Liver Disease XI score, history of atrial fibrillation, redo surgery, and body mass index >30 kg/m
CONCLUSIONS
The outcome in patients receiving durable MCS after ECLS remains limited, yet preoperative factors may allow differentiating futile patients from those with significant survival benefit.

Identifiants

pubmed: 33334424
pii: S0735-1097(20)37630-0
doi: 10.1016/j.jacc.2020.10.036
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

2956-2964

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2020 American College of Cardiology Foundation. All rights reserved.

Déclaration de conflit d'intérêts

Author Disclosures The authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Auteurs

Diyar Saeed (D)

Department of Cardiac Surgery, Leipzig Heart Center, Leipzig, Germany; Department for Cardiac Surgery, Duesseldorf University Hospital, Duesseldorf, Germany. Electronic address: diyar.saeed@helios-gesundheit.de.

Evgenij Potapov (E)

Department of Cardiac Surgery, German Heart Center Berlin, Berlin, Germany; DZHK (German Center for Cardiovascular Research), Partner Site, Berlin, Germany.

Antonio Loforte (A)

Department of Cardiac Surgery, Bologna University, Bologna, Italy.

Michiel Morshuis (M)

Department of Cardiovascular and Thoracic Surgery, Heart and Diabetes Center NRW, Bad Oeynhausen, Germany.

David Schibilsky (D)

Department of Cardiac and Vascular Surgery, Freiburg University, Freiburg, Germany.

Daniel Zimpfer (D)

Department of Cardiac Surgery, Medical University Vienna, Vienna, Austria.

Julia Riebandt (J)

Department of Cardiac Surgery, Medical University Vienna, Vienna, Austria.

Federico Pappalardo (F)

Advanced Heart Failure and Mechanical Circulatory Support Program, San Raffaele Hospital, Vita Salute University, Milan, Italy.

Matteo Attisani (M)

Department of Cardiac Surgery, University of Turin, Turin, Italy.

Mauro Rinaldi (M)

Department of Cardiac Surgery, University of Turin, Turin, Italy.

Assad Haneya (A)

Department of Cardiac Surgery, University Hospital Schleswig Holstein, Campus Kiel, Kiel, Germany.

Faiz Ramjankhan (F)

Department of Cardiothoracic Surgery, University Medical Center Utrecht, Utrecht, the Netherlands.

Dirk W Donker (DW)

Department of Cardiothoracic Surgery, University Medical Center Utrecht, Utrecht, the Netherlands.

Ulrich P Jorde (UP)

Department of Medicine, Montefiore Medical Center, Bronx, New York, USA.

Julia Stein (J)

Department of Cardiac Surgery, German Heart Center Berlin, Berlin, Germany.

Dmytro Tsyganenko (D)

Department of Cardiac Surgery, German Heart Center Berlin, Berlin, Germany.

Khalil Jawad (K)

Department of Cardiac Surgery, Leipzig Heart Center, Leipzig, Germany.

Radi Wieloch (R)

Department for Cardiac Surgery, Duesseldorf University Hospital, Duesseldorf, Germany.

Rafael Ayala (R)

Department of Cardiac and Vascular Surgery, Freiburg University, Freiburg, Germany.

Jochen Cremer (J)

Department of Cardiac Surgery, University Hospital Schleswig Holstein, Campus Kiel, Kiel, Germany.

Michael A Borger (MA)

Department of Cardiac Surgery, Leipzig Heart Center, Leipzig, Germany.

Artur Lichtenberg (A)

Department for Cardiac Surgery, Duesseldorf University Hospital, Duesseldorf, Germany.

Jan Gummert (J)

Department of Cardiovascular and Thoracic Surgery, Heart and Diabetes Center NRW, Bad Oeynhausen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH